ARTAN Bio Completes $200,000 Seed Raise for Longevity Science Platform
ARTAN Bio has raised $200,000 through decentralized funding to advance preclinical development of its engineered suppressor platform targeting nonsense mutations. The funds will support animal model validation and intellectual property filings.
